Evommune EVMN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $351.45K— | ||
| —— | —— | —— | —— | $1.82M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$4.51M-3,048% | $1.54M— | $604.67K— | $257.16K— | $153.01K— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Evommune 's total assets?
- Evommune (EVMN) holds $7.2M in total assets.
- How much debt does Evommune have?
- Evommune carries $2.0M in total debt against -$4.5M of shareholders' equity, a debt-to-equity ratio of 1.36.
- How much cash does Evommune have?
- Evommune holds $1.1M in cash and equivalents.
- Can Evommune cover its short-term obligations?
- Its current ratio is 1.20 — current assets exceed current liabilities.
- Where does Evommune 's balance sheet data come from?
- Every line is extracted from Evommune 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
